Journal of Advances in Developmental Research
E-ISSN: 0976-4844
•
Impact Factor: 9.71
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 16 Issue 2
2025
Indexing Partners
DEVELOPMENT AND VALIDATION OF A METHOD FOR TRIAMCINOLONE HEXACETONIDE IN BULK AND DOSAGE FORM BY RP-HPLC
| Author(s) | H. Padmalatha |
|---|---|
| Country | India |
| Abstract | In the present investigation, a simple, sensitive, precise and accurate Reverse phase high performance liquid Chromatography method developed and validated for estimation of Triamcinolone hexacetonide in injection formulation. This method was simple, since diluted samples are directly used without any preliminary chemical derivatisation or purification steps. Triamcinolone hexacetonide was freely soluble in ethanol, methanol and sparingly soluble in water. ACN: Methanol: water (10:30:60) was chosen as the mobile phase. The solvent system used in this method was economical. The %RSD values were within 2 and the method was found to be precise. The results expressed in tables for RP-HPLC method was promising. The RP-HPLC method is more sensitive, accurate and precise compared to the Spectrophotometric methods. This method can be used for the routine determination of Triamcinolone hexacetonide in injection formulation and in other Pharmaceutical dosage forms. |
| Keywords | RP-HPLC, Triamcinolone hexacetonide. |
| Field | Medical / Pharmacy |
| Published In | Volume 16, Issue 2, July-December 2025 |
| Published On | 2025-11-07 |
| Cite This | DEVELOPMENT AND VALIDATION OF A METHOD FOR TRIAMCINOLONE HEXACETONIDE IN BULK AND DOSAGE FORM BY RP-HPLC - H. Padmalatha - IJAIDR Volume 16, Issue 2, July-December 2025. |
Share this

CrossRef DOI is assigned to each research paper published in our journal.
IJAIDR DOI prefix is
10.71097/IJAIDR
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.